Omiq's principal product, OMIQ, is a cloud platform that enables researchers to identify drug or therapeutic interactions with a biological system through the tracking of biomarkers within lab samples, the company said.

The addition of OMIQ expands Insightful Science's offerings in flow cytometry software solutions, including Cytapex Bioinformatics and FCS Express. Additionally, the acquisition complements Insightful's growing portfolio of scientific R&D software, including GraphPad Prism, SnapGene, Geneious, Dotmatics, LabArchives, Protein Metrics, and nQuery.

OMIQ will continue as a stand-alone product but will connect with other Insightful Science solutions to provide value for customers, such as embedding proprietary analytical algorithms and supporting seamless integration between products, Insightful added.

Financial terms of the acquisition were not disclosed.

Insightful Science acquires Protein Metrics
Insightful Science has completed its transaction to acquire Protein Metrics. The acquisition expands the company's R&D value chain, and it will help resolve...

Insightful Science acquires the maker of FCS Express
Insightful Science has completed its acquisition of De Novo Software, the maker of FCS Express, a flow cytometry data analysis platform.

Insightful Science to acquire Dotmatics
Global life sciences software developer Insightful Science plans to acquire cloud-based scientific data management firm Dotmatics of the U.K.

PerkinElmer, Insightful Science to integrate software with cloud-based data
PerkinElmer has inked a collaboration with Insightful Science through which it will expand its documentation, workflow, and decision-making Signals informatics...